{"id":587,"date":"2025-10-03T14:00:14","date_gmt":"2025-10-03T14:00:14","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/03\/ectrims-2025-vidofludimus-calcium-shows-promise-against-ms\/"},"modified":"2025-10-03T14:00:14","modified_gmt":"2025-10-03T14:00:14","slug":"ectrims-2025-vidofludimus-calcium-shows-promise-against-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/03\/ectrims-2025-vidofludimus-calcium-shows-promise-against-ms\/","title":{"rendered":"ECTRIMS 2025: Vidofludimus calcium shows promise against MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/ectrims\/2025\/10\/3\/ectrims-2025-vidofludimus-calcium-continues-show-promise-ms\/\" title=\"ECTRIMS 2025: Vidofludimus calcium shows promise against MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"286\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/09\/ECTRIMS-6-800x286.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A black-and-white illustration shows nerve connections, with ECTRIMS written in red.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"153791\" \/><\/a><\/p>\n<p>Immunic Therapeutics&#8216; experimental oral therapy vidofludimus calcium continues to show a significant effect on disability worsening in people with progressive forms of multiple sclerosis (MS), even in those without signs [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/ectrims\/2025\/10\/3\/ectrims-2025-vidofludimus-calcium-continues-show-promise-ms\/\">ECTRIMS 2025: Vidofludimus calcium shows promise against MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/ectrims\/2025\/10\/3\/ectrims-2025-vidofludimus-calcium-continues-show-promise-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunic Therapeutics&#8216; experimental oral therapy vidofludimus calcium continues to show a significant effect on disability worsening in people with progressive forms of multiple sclerosis (MS), even in those without signs [&#8230;] The post ECTRIMS 2025: Vidofludimus calcium shows promise against MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com<\/p>\n","protected":false},"author":0,"featured_media":588,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=587"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/587\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/588"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}